Chinese biotech firm Genecast secures $149m in Series E round

Chinese biotech firm Genecast secures $149m in Series E round

Laboratory equipment. Photo: Pixabay

Eudora Wang

27 October, 2020

bioinformaticsChina Structural Reform FundGenecast BiotechnologyNGS

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.